Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

NCT06199934 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06199934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06199934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
September 11, 2023
Completion date
July 31, 2024
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccines, sars-cov-2